Live Price
Live Volume
Chart Volume 0
Volume 0
5 secViridian Therapeutics Market Segments
Regular Trading Hours
-0.53(-1.73%)
| Open | $30.69 |
|---|---|
| Close | $30.16 |
| Low | $30.10 |
| Low Change | -0.60 (-1.94%) |
| High | $31.37 |
| High Change | +0.68 (+2.22%) |
| Range | $1.28 |
| Volume | 1.355M |
| Dollar Volume | $40.87M |
Premarket
+0.00(+0.00%)
| Open | $30.90 |
|---|---|
| Close | $30.90 |
| Low | $30.90 |
| Low Change | 0.00 (0.00%) |
| High | $30.90 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 111 |
| Dollar Volume | $3.43K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $30.87 |
|---|---|
| Close | $30.87 |
| Low | $30.86 |
| Low Change | -0.01 (-0.03%) |
| High | $30.87 |
| High Change | +0.00 (+0.00%) |
| Range | $0.01 |
| Volume | 222.807K |
| Dollar Volume | $6.88M |
Regular Trading Hours Yesterday
+0.62(+2.05%)
| Open | $30.24 |
|---|---|
| Close | $30.86 |
| Low | $29.81 |
| Low Change | -0.43 (-1.42%) |
| High | $30.96 |
| High Change | +0.72 (+2.38%) |
| Range | $1.15 |
| Volume | 971.265K |
| Dollar Volume | $29.97M |
Premarket Yesterday
-0.05(-0.16%)
| Open | $30.40 |
|---|---|
| Close | $30.35 |
| Low | $30.35 |
| Low Change | -0.05 (-0.16%) |
| High | $30.40 |
| High Change | +0.00 (+0.00%) |
| Range | $0.05 |
| Volume | 1.011K |
| Dollar Volume | $30.68K |
Viridian Therapeutics News
5 months agoinvesting.comComcast, Viridian Therapeutics jump premarket; Doximity slips
7 months agoinvesting.comViridian Therapeutics stock surges on positive trial results
7 months agoinvesting.comViridian Therapeutics stock tumbles after Amgen Tepezza data
8 months agobloomberg.comUS Premarket Movers: Alcoa, Spire, Sysco, Viridian Therapeutics
8 months agoinvesting.comViridian Therapeutics stock tumbles despite trial success
Viridian Therapeutics Top Trades
Viridian Therapeutics's top trade so far today returned +2.22%, while the top short trade returned -3.86%.
Viridian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $30.72 |
|---|---|
| 10 Day Moving Average (SMA10) | $29.01 |
| 20 Day Moving Average (SMA20) | $26.13 |
| 50 Day Moving Average (SMA50) | $22.75 |
| 100 Day Moving Average (SMA100) | $21.86 |
| 200 Day Moving Average (SMA200) | $21.56 |
Viridian Therapeutics Statistics
| Average Volume (30 Days) | 2.69M |
|---|---|
| P/E Ratio (Current) | -8.71 |
| EPS (Current) | -$3.50 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$343.44M |
| Cash Ratio | 2.47 |
| Current Ratio | 14.46 |
| Quick Ratio | 14.46 |
| Debt to Equity | 0.63 |
| Enterprise Value | $3.65B |
| EV to EBITDA | -7.79 |
| EV to Sales | 138.83 |
| Price to Book | 5.96 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 131.56 |
| Return on Assets | -0.39% |
| Return on Equity | -0.68% |
Viridian Therapeutics Stock Splits
There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Nov 13, 2020 | Reverse | 15:1 |
| Nov 7, 2016 | Reverse | 15:1 |
Viridian Therapeutics Dividends
There have been no dividends for Viridian Therapeutics (VRDN).